macrolide resistance

Related by string. * macrolides . Macrolides . Macrolide : penicillin macrolide . macrolide resistant bacteria . macrolide resistant . macrolide antibiotics . macrolide antibiotic / resistances . Resistances . RESISTANCE . Resistance : Lord Resistance Army . REACHES INITIAL RESISTANCE LEVEL . TO APPROACH RESISTANCE AT . CROSSES PIVOT POINT RESISTANCE . Reaches Initial Resistance * *

Related by context. Frequent words. (Click for all words.) 66 tigecycline 64 candidiasis 63 S aureus 62 Human papillomavirus 61 penicillins 61 multidrug resistance 61 daptomycin 61 HCV infections 60 rhinosinusitis 60 antibiotic resistant strains 60 Chlamydia trachomatis 60 Staph aureus 60 quinolones 60 S. aureus infections 60 immunocompromised patients 60 H pylori 59 methicillin resistant S. aureus 59 corticosteroid therapy 59 nosocomial pneumonia 59 NNRTIs 59 chemotherapy induced neutropenia 59 gastrointestinal stromal tumors GIST 58 methicillin resistant 58 PCV7 58 S. pneumoniae 58 CMV infection 58 invasive fungal infections 58 indinavir 58 Clostridium difficile infection 58 macrolide 58 Antibiotic resistance 58 amphotericin B 58 Hospital Acquired Infections 58 nosocomial 58 cephalosporins 58 multidrug resistant 57 Onychomycosis 57 calcineurin inhibitors 57 C. difficile infections 57 pneumococcal vaccination 57 antibiotic prophylaxis 57 CDAD 57 Human Papilloma Virus 57 Human Papilloma Virus HPV 57 endophthalmitis 57 meningococcus 57 MGUS 57 macrolides 57 Ceftaroline 57 systemic toxicity 57 Streptococcus pyogenes 57 Herpes Simplex Virus 57 Azilect ® 57 COPD exacerbations 57 Amantadine 56 pneumoniae 56 anemias 56 pneumococcal infections 56 Genital herpes 56 cephalosporin 56 herpes infections 56 secondary hyperparathyroidism 56 staphylococci 56 VZV 56 Chlamydia pneumoniae 56 Zolinza 56 Clostridium difficile associated 56 vaccinees 56 MRSA strains 55 GnRH agonists 55 atopic eczema 55 HCV infection 55 Golimumab 55 C. difficile infection 55 proteasome inhibitor 55 Periodontitis 55 conjugate vaccine 55 causative agents 55 Influenza vaccination 55 serogroups 55 nephrotoxicity 55 Streptococcus pneumoniae 55 resistant pathogens 55 Acinetobacter baumannii 55 HBV infection 55 cytostatic 55 antiviral therapies 55 neuraminidase inhibitor 55 Community Acquired Pneumonia 55 cSSSI 55 hematologic toxicity 55 chronic HBV infection 55 antibiotic prescribing 55 antifungal agent 55 pancreatic insufficiency 55 immunosuppressive agents 55 TNF α 55 CMV disease 55 seroprotection 55 falciparum malaria 55 hepatitis C infection

Back to home page